Ann Dermatol. 2008 Sep;20(3):113-9. doi: 10.5021/ad.2008.20.3.113. Epub 2008 Sep 30.
Differential Expression of TGF-β Isoforms in Human Kerationocytes by Narrow Band UVB.
Annals of dermatology
Moon Chul Jung, Min Kyung Shin, Kyung Kook Hong, Ki Heon Jeong, Nack In Kim
Affiliations
Affiliations
- Department of Dermatology, School of Medicine, Kyung Hee University, Seoul, Korea.
PMID: 27303173
PMCID: PMC4903960 DOI: 10.5021/ad.2008.20.3.113
Abstract
BACKGROUND: Transforming growth factor-β (TGF-β), a multifunctional growth factor, has three isoforms: TGF-β1, TGF-β2, and TGF-β3. Different isoforms of TGF-β are associated with different proliferation and differentiation states of the epidermis. Narrow band ultraviolet B (NBUVB) emits a concentrated UVB source of 311 nm. NBUVB 1,000 mJ/cm(2) induces apoptosis in approximately 50% of keratinocytes.
OBJECTIVE: The purpose of this study was to evaluate whether irradiation with NBUVB would alter the expression and production of TGF-β1, 2, and 3.
METHODS: We measured TGF-β1, 2, and 3 mRNA and TGF-β1 and 2 protein levels at 800, 1,000, and 1,200 mJ/cm(2) for 24 hours and 48 hours.
RESULTS: TGF-β1 mRNA levels were increased at both 24 hr and 48 hr, TGF-β2 mRNA levels were decreased at both 24 hr and 48 hr, and TGF-β3 mRNA levels were increased at 24 hr and similar to control at 48 hr. TGF-β1 protein levels were increased at 48 hr but decreased at 24 hr. TGF-β2 protein levels were decreased at both 24 hr and 48 hr.
CONCLUSION: The results suggest a possible role for TGF-β1 after NBUVB irradiation and opposing roles for TGF-β1 and TGF-β2 isoforms in NBUVB irradiation.
Keywords: Keratinocytes; NBUVB; Transforming growth factor β (TGF-β)
References
- J Photochem Photobiol B. 2006 Feb 1;82(2):132-9 - PubMed
- Cancer Res. 1992 Dec 15;52(24):6949-52 - PubMed
- Exp Cell Res. 1999 Jun 15;249(2):377-85 - PubMed
- Carcinogenesis. 2000 Jun;21(6):1087-95 - PubMed
- Br J Dermatol. 2005 Oct;153(4):733-9 - PubMed
- Health Technol Assess. 2000;4(40):1-125 - PubMed
- J Biol Chem. 1999 Aug 13;274(33):23358-67 - PubMed
- Int J Oncol. 1998 Oct;13(4):781-9 - PubMed
- Cytokine. 2002 Aug 7;19(3):121-5 - PubMed
- Am J Pathol. 2005 Oct;167(4):1005-19 - PubMed
- Cytokine. 2004 Jan 21;25(2):45-51 - PubMed
- J Biol Chem. 1987 May 15;262(14):6443-6 - PubMed
- Am J Pathol. 1993 Aug;143(2):368-80 - PubMed
- J Clin Invest. 2000 Feb;105(3):253-60 - PubMed
- Exp Gerontol. 2000 Feb;35(1):53-62 - PubMed
- Nature. 1982 Feb 4;295(5848):434-6 - PubMed
- Cell. 1992 Jun 26;69(7):1067-70 - PubMed
- J Cell Sci. 1994 Aug;107 ( Pt 8):2219-28 - PubMed
- J Pathol. 2000 Apr;190(5):579-88 - PubMed
- Proc Natl Acad Sci U S A. 1986 Jun;83(12):4167-71 - PubMed
- Kidney Int. 2003 Sep;64(3):844-56 - PubMed
- Radiat Res. 1997 Feb;147(2):148-55 - PubMed
- J Cell Biol. 1991 Nov;115(4):1091-105 - PubMed
- J Biol Chem. 1986 Mar 25;261(9):4337-45 - PubMed
- Invest Ophthalmol Vis Sci. 2006 May;47(5):1886-94 - PubMed
- Cancer Res. 1994 May 1;54(9):2347-58 - PubMed
- Biomarkers. 2003 Sep-Oct;8(5):437-43 - PubMed
- Oncogene. 1996 Apr 4;12(7):1387-96 - PubMed
- J Korean Med Sci. 2004 Dec;19(6):853-8 - PubMed
Publication Types